Found 10 matching trials
Bendamustine, Prednisone and Velcade® for First-line Treatment of Patients With Symptomatic Multiple Myeloma PHASE2 The purpose of this study is to improve efficacy of treatment for patients ...
Show More Location
Mannheimer Onkologie Praxis
Learn More & Join Trial
A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd)-Based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With Primary Plasma Cell Leukemia PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults PHASE1 This research study is evaluating a combination of drugs considered standar...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Isa-VRD in TIE HRMM PHASE4 This is a multicenter, prospective, randomized controlled trial designed to...
Show More Learn More & Join Trial
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT PHASE3 This is a randomised, multicentre, controlled, open-label, Phase III global...
Show More Learn More & Join Trial
Vorinostat Plus FND in Relapsed or Refractory Mantle Cell Lymphoma PHASE2 1. Rationale In mantle cell lymphoma, the conventional chemotherapy achieve...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Efficacy of Integrated Induction-Consolidation Chemotherapy and Transplantation for Adult Acute Myeloid Leukemia: Multicenter Study PHASE2 This is a multicenter, single-arm, open-label clinical study designed to ev...
Show More Location
Shanxi Bethune Hospital
Learn More & Join Trial
A Study of VRd-based Regimen Followed by BCMA CAR-T Therapy in Transplant-Ineligible Patients With New-diagnosed Multiple Myeloma PHASE2 This is a single-arm, open-label study to evaluate the efficacy and safety ...
Show More Status
Active Not Recruiting
Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
MRD-Adaptive Guided Immunotherapy With CAR-T for Transplant-Ineligible Patients With Multiple Myeloma PHASE2 This is a prospective, single-center, clinical study to evaluate the effica...
Show More Location
Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences
Learn More & Join Trial
Evaluation iNduction, Consolidation and Maintenance Treatment With Isatuximab , Carfilzomib, LEnalidomide and Dexamethasone PHASE2 A Clinical Phase II, multicenter, Open-label study evaluating iNduction, co...
Show More Status
Active Not Recruiting
Location
Vivantes Am Urban
Learn More & Join Trial